We speculate that this may be due to the tumor’s increased expression of CEA in these patients, given that CEA can directly bind to CEA receptors on the surface of hepatocytes, or interact with signal receptors such as DR5 and TGF-βR1. This evidence concerns the gene CEACAM5 and neoplasm.